Hematopoietic stem cell development and regeneration is controlled by a number of regulators including the WNT, BMP, and Notch pathways. In the previous grant, we found that the Wnt pathway was activated by PGE2, leading to enhanced homing and self-renewal of blood stem cells. We now wish to determine the mechanism by which signaling pathways such as the wnt-PGE2 pathway leads to these effects. Many signal transduction pathways terminate with specific signaling transcription factors, although the action of these DNA- binding proteins in stem and progenitor cells has not been defined. Our recent studies have demonstrated that signaling transcription factors bind adjacent to the cell-specific transcription regulators on lineage-specific genes in hematopoietic cells. We hypothesize that these signaling transcription factors reinforce the intrinsic hematopoietic program during regeneration, conferring an advantage to the recovering cells. We plan to use ChIPSeq technology to determine the state of chromatin and the characteristics of transcription factors binding on regions of lineage- and stage-specific genes. The recruitment and function of the signaling- and cell- specific transcription regulators will be evaluated during hematopoietic regeneration after injury from irradiation and during phenylhydrazine-induced anemia. Our work demonstrates that recruitment of signaling transcription factors occurs to blood-specific genes during differentiation of hematopoietic cells. Progenitor and precursor- expressed genes are co-bound by GATA2 and the BMP-stimulated transcriptional regulator SMAD1, but erythroid-specific genes in progenitors are not bound by SMAD1. As cells differentiate, there is a shift of SMAD1 from binding to progenitor genes to a position on erythroid genes adjacent to GATA1. The mechanism of the recruitment of SMAD1 from the progenitor to erythroid genes will be studied, identifying the factors that facilitate this process Transcription and chromatin factors required for stem and progenitor formation in zebrafish will be evaluated functionally for their ability to block or enhance SMAD1 binding to lineage-specific genes in murine and human hematopoietic cells. Chromatin factors associated with GATA1 and GATA2, or induced by GATA1 during differentiation will be tested for their ability to promote or prevent SMAD1 binding adjacent to the GATA-factors. Our studies will lead to a fundamental understanding of the biology of regeneration and may define methods that could be used in the clinic for the expansion of stem and progenitor cells for marrow transplantation or therapies for blood disorders such as thalassemia or sickle cell anemia.

Public Health Relevance

Blood stem cells have the ability to self-renew and differentiate, and have a remarkable capability to repopulate the immune system in a host that has been irradiated or treated with chemotherapy. We are examining the mechanism of the regeneration. We found that specific DNA-binding proteins are stimulated by developmental growth factors, and these signaling pathway transcription factors bind adjacent to the cell-specific factors on blood genes. By understanding the mechanism of this co-binding, we will be able to better manipulate the differentiation or regenerative process for therapies of sickle cell anemia and thalassemia, and other disorders that benefit from marrow or cord blood transplantation.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL048801-21
Application #
8514954
Study Section
Molecular and Cellular Hematology (MCH)
Program Officer
Thomas, John
Project Start
1992-08-01
Project End
2017-05-31
Budget Start
2013-06-01
Budget End
2014-05-31
Support Year
21
Fiscal Year
2013
Total Cost
$414,120
Indirect Cost
$176,120
Name
Children's Hospital Boston
Department
Type
DUNS #
076593722
City
Boston
State
MA
Country
United States
Zip Code
02115
Huang, Jialiang; Liu, Xin; Li, Dan et al. (2016) Dynamic Control of Enhancer Repertoires Drives Lineage and Stage-Specific Transcription during Hematopoiesis. Dev Cell 36:9-23
Liu, W; Wu, M; Huang, Z et al. (2016) c-myb hyperactivity leads to myeloid and lymphoid malignancies in zebrafish. Leukemia :
Wakabayashi, Aoi; Ulirsch, Jacob C; Ludwig, Leif S et al. (2016) Insight into GATA1 transcriptional activity through interrogation of cis elements disrupted in human erythroid disorders. Proc Natl Acad Sci U S A 113:4434-9
Burberry, Aaron; Suzuki, Naoki; Wang, Jin-Yuan et al. (2016) Loss-of-function mutations in the C9ORF72 mouse ortholog cause fatal autoimmune disease. Sci Transl Med 8:347ra93
Giani, Felix C; Fiorini, Claudia; Wakabayashi, Aoi et al. (2016) Targeted Application of Human Genetic Variation Can Improve Red Blood Cell Production from Stem Cells. Cell Stem Cell 18:73-8
Hagedorn, Elliott J; Cillis, Jennifer L; Curley, Caitlyn R et al. (2016) Generation of Parabiotic Zebrafish Embryos by Surgical Fusion of Developing Blastulae. J Vis Exp :
Aranda-Orgilles, Beatriz; Saldaña-Meyer, Ricardo; Wang, Eric et al. (2016) MED12 Regulates HSC-Specific Enhancers Independently of Mediator Kinase Activity to Control Hematopoiesis. Cell Stem Cell 19:784-799
Nasrallah, Rabab; Fast, Eva M; Solaimani, Parham et al. (2016) Identification of novel regulators of developmental hematopoiesis using Endoglin regulatory elements as molecular probes. Blood 128:1928-1939
CHARGE Consortium Hematology Working Group (2016) Meta-analysis of rare and common exome chip variants identifies S1PR4 and other loci influencing blood cell traits. Nat Genet 48:867-76
Gao, Xin; Wu, Tongyu; Johnson, Kirby D et al. (2016) GATA Factor-G-Protein-Coupled Receptor Circuit Suppresses Hematopoiesis. Stem Cell Reports 6:368-82

Showing the most recent 10 out of 82 publications